Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
AROMATIC RING COMPOUND
Document Type and Number:
WIPO Patent Application WO/2013/122028
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide an aromatic ring compound exhibiting GPR40 agonist activity. The compound represented by formula (I) (refer to the description for information pertaining to each symbol in the formula) or a salt of said compound exhibits GPR40 agonist activity and is useful as an agent for the prevention or treatment of diabetes.

Inventors:
MIWATASHI SEIJI (JP)
SUZUKI HIDEO (JP)
OKAWA TOMOHIRO (JP)
MIYAMOTO YASUFUMI (JP)
YAMASAKI KEN (JP)
HITOMI YUKO (JP)
HIRATA YASUHIRO (JP)
SHIBUYA AKITO (JP)
Application Number:
JP2013/053196
Publication Date:
August 22, 2013
Filing Date:
February 12, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1 Doshomachi 4-chome, Chuo-ku Osaka-sh, Osaka 45, 〒5410045, JP)
International Classes:
C07C59/68; A61K31/192; A61K31/195; A61K31/351; A61K31/381; A61K31/4166; A61K31/4245; A61K31/426; A61K31/44; A61K31/4418; A61K31/444; A61K31/505; A61K31/506; A61P9/10; A61P43/00; C07C59/70; C07C59/72; C07C229/34; C07C233/47; C07C255/37; C07C255/46; C07C317/44; C07C323/62; C07D213/55; C07D213/64; C07D213/65; C07D231/12; C07D239/26; C07D271/10; C07D277/24; C07D285/12; C07D309/06; C07D333/38; C07D401/12
Domestic Patent References:
WO2011067174A12011-06-09
WO2004041266A12004-05-21
WO2002088084A12002-11-07
WO2009048527A12009-04-16
WO2006059245A22006-06-08
WO2002088084A12002-11-07
WO2004041266A12004-05-21
WO2005063729A12005-07-14
WO2007013694A12007-02-01
WO2007018314A22007-02-15
WO2008093639A12008-08-07
WO2008099794A12008-08-21
WO2004106276A12004-12-09
WO2005063725A12005-07-14
WO2005087710A12005-09-22
WO2005095338A12005-10-13
WO2007013689A12007-02-01
WO2008001931A22008-01-03
WO2006112549A12006-10-26
WO2007028135A22007-03-08
WO2008047821A12008-04-24
WO2008050821A12008-05-02
WO2008136428A12008-11-13
WO2008156757A12008-12-24
WO2001014372A22001-03-01
WO2004039365A12004-05-13
WO1997010224A11997-03-20
WO2002006234A12002-01-24
WO2004048363A12004-06-10
WO2005030740A12005-04-07
WO2005058823A12005-06-30
WO2005113504A12005-12-01
Foreign References:
JP2007506666A2007-03-22
JP2011500562A2011-01-06
JP2008520647A2008-06-19
JP2003238538A2003-08-27
JPH08333287A1996-12-17
EP0442448A21991-08-21
US5011851A1991-04-30
EP0434034A11991-06-26
US5187188A1993-02-16
JP2012028942A2012-02-09
Other References:
See also references of EP 2816023A4
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 15, no. 21, 2007, pages 6692 - 6704
JOURNAL OF MEDICINAL CHEMISTRY, vol. 35, no. 19, 1992, pages 3483 - 3497
MOLECULAR PHARMACOLOGY, vol. 62, no. 5, 2002, pages 1103 - 1111
JOURNAL OF MEDICINAL CHEMISTRY, vol. 35, no. 19, 1992, pages 3498 - 3512
JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, no. 24, 1993, pages 3871 - 3883
"Design of Molecules", vol. 7, 1990, HIROKAWA SHOTEN, article "Development of Pharmaceuticals", pages: 163 - 198
"Protective Groups in Organic Synthesis", 1980, JOHN WILEY AND SONS
Attorney, Agent or Firm:
TAKASHIMA, Hajime (Meiji Yasuda Seimei Osaka Midosuji Bldg, 1-1 Fushimimachi 4-chome, Chuo-ku, Osaka-sh, Osaka 44, 〒5410044, JP)
Download PDF:
Claims: